Back to products
GLP- 1(T) 10mg, 20mg , 30mg, 40mg
Price range: $ 170.00 through $ 180.00
Recently View Products
CJC-1295 DAC – 2mg & 5mg
Price range: $ 300.00 through $ 345.00
Select options
This product has multiple variants. The options may be chosen on the product page
FOXO4-DRI – 10mg & 20mg
Price range: $ 300.00 through $ 550.00
Select options
This product has multiple variants. The options may be chosen on the product page
FOX04-DRI (Retro-Inverso) is a synthetic, slightly modified version of the standard FOXO4 protein. The modification prolongs half-life of the protein and allows it to interfere with normal FOXO4 function. FOXO4-DRI has been shown in research to prevent normal FOXO4 binding to p53, thereby allowing for elimination of senescent cells, improved organ function, and younger tissue “biological age.” FOXO4-DRI impacts insulin signaling, cell cycle regulation, and oxidative stress signaling pathways. FOXO4-DRI is a cell penetrating peptide shown to selectively induce apoptosis of senescent cells thereby reversing effects of aging in animal studies.
Kisspeptin – 5mg &10mg
Price range: $ 70.00 through $ 75.00
Select options
This product has multiple variants. The options may be chosen on the product page
NAD+ 100MG & 500MG
Price range: $ 170.00 through $ 175.00
Select options
This product has multiple variants. The options may be chosen on the product page
SS-31 – 10mg & 20mg
Price range: $ 100.00 through $ 150.00
Select options
This product has multiple variants. The options may be chosen on the product page
Tesamorelin – 5mg & 10mg
Price range: $ 70.00 through $ 75.00
Select options
This product has multiple variants. The options may be chosen on the product page
Tesamorelin, is a syntheitic peptide consiting of 44 amino acids. It is a growth-hormone-releasing hormone (GHRH) analogue researched for the treatment of HIV-associated lipodystrophy (dysfunctional, toxic fat deposition). It is also being researched for its ability to improve peripheral nerve health, slow the progression of mild cognitive impairment, and the reduction visceral fat. This peptide has been found to reduce adiposity by nearly 20% in this population. Research suggests that tesamorelin is approximately 4 times more effective in reducing adiposity than all of the other available therapies combined .